Doctor profile · Federal record
Dr. Brenen Swofford, D.O.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Student in an Organized Health Care Education/Training Program · Spokane, WA
- NPI 1447614110
- Accepts Medicare
- 10 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
605 E Holland Ave Ste 100
Spokane, WA 992181246
(509) 228-1000
fax (509) 252-9300 - Additional location
-
1111 E McDowell RD, Banner University Medical Center Phoenix Ll2
Phoenix, AZ 850062612
(602) 839-2296 - Additional location
-
800 Rose St Ste Cc-402
Lexington, KY 405367001
(859) 323-1786
fax (859) 257-7715 - Mailing address
-
1204 N Vercler RD
Spokane Valley, WA 992161020
Credentials & registration
- NPI registered
- April 2016 — 10 yrs on file
- Profile last updated
- July 5, 2022
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Washington #OP61212767 · Kentucky #04511
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1447614110. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
70,957
Distinct HCPCS
10
Medicare allowed
$1,458,270
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 18,000 | 11 | $1 | |
J9299 |
Injection, nivolumab, 1 mg | 15,738 | 15 | $30 | |
J9271 |
Injection, pembrolizumab, 1 mg | 9,201 | 16 | $54 | |
J0897 |
Injection, denosumab, 1 mg | 7,020 | 51 | $23 | |
J9267 |
Injection, paclitaxel, 1 mg | 5,285 | 18 | $0 | |
J0185 |
Injection, aprepitant, 1 mg | 4,420 | 17 | $2 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,554 | 71 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 970 | 38 | $1 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 860 | 36 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 783 | 205 | $8 |
In context: peer comparison
Among 11 peers in Spokane Hematology & Oncology Physician, average services per provider: 1,717. This provider delivers 41× the peer median.Open Payments
Industry payments received
All-time total
$325
Transactions
16
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $165.72 | |
| Janssen Biotech, INC. | 3 | $77.32 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $25.95 | |
| Acrotech Biopharma INC. | 1 | $24.68 | |
| Fennec Pharmaceuticals, INC. | 1 | $16.49 | |
| Celgene Corporation | 1 | $15.21 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
440
Patients
110
Total drug cost
$1,239,447
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ondansetron Odt (Ondansetron) | Brand | 53 | 39 | $1,676 |
| Oxycodone Hcl | Generic | 43 | 19 | $1,164 |
| Prednisone | Generic | 42 | 15 | $367 |
| Calquence (Acalabrutinib Maleate) | Brand | 39 | 0 | $574,684 |
| Imbruvica (Ibrutinib) | Brand | 35 | 0 | $591,455 |
| Acyclovir | Generic | 32 | 0 | $254 |
| Prochlorperazine Maleate | Generic | 31 | 26 | $1,204 |
| Xarelto (Rivaroxaban) | Brand | 30 | 0 | $18,084 |
| Olanzapine | Generic | 24 | 11 | $403 |
| Tramadol Hcl | Generic | 24 | 0 | $326 |
Hospital affiliations
Frequently asked questions
What is Dr. Brenen Swofford's medical specialty?
Dr. Brenen Swofford practices Hematology & Oncology Physician in Spokane, WA.
Where does Dr. Brenen Swofford practice?
Dr. Brenen Swofford practices at 605 E Holland Ave Ste 100, Spokane, WA 992181246. Office phone: 5092281000.
What is Dr. Brenen Swofford's NPI?
Dr. Brenen Swofford's National Provider Identifier (NPI) is 1447614110, issued by NPPES.
Does Dr. Brenen Swofford accept Medicare assignment?
Yes. Dr. Brenen Swofford accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Brenen Swofford commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, nivolumab, 1 mg (HCPCS J9299); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.